By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ZS Pharma 

508 Wrangler Drive
Suite 100
Coppell  Texas  75019  U.S.A.
Phone: 650-458-4100 Fax: 650-458-0084



Company News
ZS Pharma (ZSPH) To Present At J.P. Morgan Healthcare Conference 1/6/2015 10:14:43 AM
ZS Pharma (ZSPH) To Ring The Nasdaq Stock Market Opening Bell 12/15/2014 7:37:04 AM
ZS Pharma (ZSPH) Announces Publication Of Results From Phase 3 Study Of ZS-9 In Patients With Hyperkalemia In The New England Journal of Medicine 11/21/2014 11:21:28 AM
ZS Pharma (ZSPH) Hosts And Webcasts Investor Event 11/20/2014 2:04:33 PM
ZS Pharma (ZSPH) Presents Positive Results From HARMONIZE (ZS004), A Second Phase 3 Clinical Trial Of ZS-9 In Patients With Hyperkalemia, At The American Heart Association Scientific Meeting And Announces Simultaneous Publication Of Results In JAMA 11/17/2014 7:32:01 AM
ZS Pharma (ZSPH) Reports Third Quarter 2014 Financial Results And Provides ZS-9 Program Update 11/11/2014 7:53:32 AM
ZS Pharma (ZSPH) Announces Late Breaking Presentation Of Phase 3 HARMONIZE (ZS004) Trial Results In Patients With Hyperkalemia At American Heart Association Annual Meeting 11/6/2014 7:20:07 AM
ZS Pharma (ZSPH) Announces Multiple Presentations From ZS003, A Phase 3 Trial Of ZS-9, At The American Society of Nephrology Annual Meeting 10/31/2014 7:30:10 AM
ZS Pharma (ZSPH) To Present At The Credit Suisse Annual Healthcare Conference 10/29/2014 7:22:07 AM
Analysts Say ZS Pharma (ZSPH) Continues To Gain On Drug Approval 9/26/2014 12:10:26 PM